For the development of mechanistic assays in immunotoxicology, the phenotype, cytokine production, and stimulatory function of dendritic cells (DCs) were assessed after incubation with the chemical haptens aminophenol, chlorpromazine hydrochloride, dinitrochlorobenzene (DNCB), and with the DNCB-corresponding tolerogen DCNB, the metal allergen nickel sulfate, the irritants sodium dodecyl sulfate and benzoic acid, as well as with staphylococcal enterotoxin B (SEB) and lipopolysaccharide (LPS). DCs were differentiated from human monocytes by in vitro exposure to GM-CSF and interleukin-4 (IL-4) for 7 days. Flow cytometric data revealed that only representative haptens increased the surface expression of HLA-DR, CD86, CD40, and of CD54 on DCs when compared to irritants or to the tolerogen. This event was associated with an increased ability of DCs to stimulate T cell proliferation. Moreover, after incubation with the haptens, but not with the irritants or the tolerogen, a higher production of TNF-␣ by DCs was observed. Under our experimental conditions, no release of IL-1␤, IL-10, or IL-12 was detected. Compared to the activation elicited by haptens, SEB strongly up-regulated HLA-DR and costimulatory molecule expression. In agreement with this effect, there was a marked release of TNF-␣ and a slight production of IL-12. IL-1␤ and IL-10 were not detected in the culture medium. Finally, SEB-pulsed DCs showed a strong T-cell-stimulating activity. These data underline the activating potential of haptens versus irritants or a tolerogen on DC functions. The different levels of DC activation by haptens and SEB suggested that distinct cellular events were involved.
Dendritic cells (DCs) are the most potent antigen-presenting cells (APCs) of the immune system. They are critically involved in the initiation of primary immune responses, graft rejection, autoimmune diseases, and generation of T-cell-dependent humoral immune responses (Steinman et al. 1991) . During their life cycle, DCs undergo phenotypic and functional changes corresponding to maturation. The ability of mature DCs to prime naive CD4ϩ and CD8ϩ T cells is related to their high expression of major histocompatibility complex (MHC) molecules, adhesion and co-stimulatory molecules (Romani et al., 1989) , and also to their production of cytokines (Enk and Katz, 1992; Ma et al., 1996) . It is crucial that DCs recognize and are activated preferentially by antigen-associated molecular structures that lead to their maturation. Lipopolysaccharide (LPS), a common component of a gram-negative bacterial wall, stimulates the production of cytokines and the expression of co-stimulatory molecules by DCs through a soluble CD14-dependent pathway . Moreover, certain low-molecular-weight organic chemicals (or haptens) of pharmacological or industrial importance, by forming immunogenic conjugates with a carrier molecule, result in the development of hypersensitivity reaction (Basketter et al. 1995; De Weck, 1983) . In contrast, primary irritants that cannot sensitize induce inflammation. DCs play an important role in the initiation of these allergic reactions. Different studies have reported a good correlation between sensitizing capacity in vivo and the chemical reactivity determined in vitro by conjugation to the amino group of certain amino-acids. The applicability of the principle of covalent binding to drug allergy in humans has been demonstrated in the case of penicillin, which covalently binds to lysine groups of proteins such as serum albumin, or to MHC molecules, or to the peptide they present (Brander et al., 1995; De Weck, 1983) . Other compounds such as staphylococcal enterotoxins (SE) A, B, or E share the ability to bind to MHC class II molecules outside the conventional antigenbinding groove to interact with particular TCR V␤. This leads to the stimulation of a much higher proportion of T cells than observed in the case of any conventional antigen (Marrack and Kappler, 1990) . Antigens that share these properties are termed "superantigens."
There are culture methods for the generation of DCs from precursors in blood or bone marrow (Meierhoff and Krause, 1998) . We generated such DCs from human monocytes cultured with granulocyte/macrophage-colony stimulating factor (GM-CSF) and interleukin (IL)-4 (Chapuis et al., 1997) . Cells obtained under this selected condition are considered to be DCs according to morphology, phenotype, and function, and they have been successfully used as APCs in vitro (Sallusto and Lanzavecchia, 1994) . To establish mechanistic studies in immunotoxicology, we first investigated how human monocytederived DCs (M-DCs) responded in vitro to treatment with chemical haptens (dinitrochlorobenzene, aminophenol, chlorpromazine) or to the metal allergen, nickel sulfate, with the irritants sodium dodecyl sulfate and benzoic acid or the DNCB-related tolerogen dichloronitrobenzene, DCNB (Enk and Katz, 1992, Rambukkana et al., 1996) . For this purpose, the surface expression of HLA-DR and of co-stimulatory molecules involved in T-cell activation was examined. The cytokine release and the stimulatory potential of M-DCs to T cells were assessed in parallel. These effects were compared to the activity of two toxins, LPS and SEB, on M-DCs. macia, Uppsala, Sweden) gradient centrifugation of heparinized fresh leukocyte-enriched buffy coats (obtained from the Blutspendezentrum, Basel). These PBMC were plated (1 ϫ 10 7 /3 ml per well) into 6-well culture plates (Falcon, Becton Dickinson, Germany) in RPMI 1640 supplemented with 2 mM L-glutamine, 0.05 mg/ml gentamicin, 10% fetal bovine serum (endotoxin-free, Myoclone), and 10 mM N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid buffer solution (all from Gibco, Switzerland). After 2-h adhesion at 37°C, non-adherent cells were gently removed by washing. Adherent cells (monocytes) were cultured at 37°C in humidified 5% CO 2 in air, in supplemented RPMI 1640 containing 600 U/ml recombinant human (rh)GM-CSF and 60 ng/ml rhIL-4 (a gift from Dr. P. Ramage, Novartis Pharma, Basel). Every 2-3 days, 1 ml spent medium was replaced by 1.5 ml fresh medium containing sufficient rhGM-CSF and rhIL-4 to yield final concentrations of 600 U/ml and 100 ng/ml, respectively.
MATERIAL AND METHODS

Generation
Treatment of cultured M-DCs. Seven days after the beginning of the culture with rhGM-CSF and rhIL-4, dead cells were removed by Ficoll-Paque gradient centrifugation. Then, M-DCs were plated at 500,000 cells per 0.5-ml medium per well of 24-well plates (Falcon) and incubated for 48 h with subtoxic concentrations of reference chemicals (Kimber et al., 1994) (all from Sigma, Switzerland) as severe allergens (or severe haptens): 2,4-dinitrochlorobenzene (DNCB; 1-6 g/ml), 4-aminophenol (4-AP; 1-8 g/ml); moderate allergens (or moderate haptens): chlorpromazine-hydrochloride (Clpz; 0.1-0.5 g/ml), nickel sulfate (NiSO 4 ; 20 -50 g/ml); tolerogen: 2,4-dichloronitrobenzene (DCNB; 10 -20 g/ml) (Rambukkana et al. 1996) ; irritants: sodium dodecyl sulfate (SDS; 10 -20 g/ml), benzoic acid (B.Ac; 10 -20 g/ml). DCNB and DNCB were solubilized with non-cytotoxic concentration (Յ0.02%) of dimethylsulfoxide (DMSO, Sigma). M-DCs were also stimulated with concentrations ranking from 1 to 100 ng/ml LPS (E.coli J5, Calbiochem, Switzerland) and from 1 to 10 pg/ml SEB (BioScience Products, Switzerland). Tumor necrosis factor (TNF)-␣ (Genzyme, Switzerland) was used as a positive control for M-DC function. The highest active and subtoxic concentration for each compound was determined in a pilot experiment. Cell viability was assessed by trypan blue exclusion test after each treatment (data not shown).
Flow cytometric measurement of surface antigen expression. The surface expression of HLA-DR and of co-stimulatory molecules was analyzed by flow cytometry after a 48-h treatment. M-DCs were incubated with fluorochrome-conjugated mouse monoclonal antibodies or with isotype-matched mouse control antibodies (Pharmingen, Germany). Fluorescein isothiocyanate (FITC)-conjugated anti-CD1a; R-Phycoerythrin (R-PE)-conjugated anti-HLA-DR; FITC-conjugated anti-CD40; R-PE-conjugated anti-CD54; R-PE-conjugated anti-CD86; FITC-conjugated anti-CD80; R-PE-conjugated anti-CD14; R-PE-conjugated anti-CD8; FITC-conjugated anti-CD4; R-PE-conjugated anti-CD56; FITC-conjugated anti-CD19. Incubations were performed on ice for 30 min in PBS supplemented with 2% bovine serum albumin and 0.03% Na azide. M-DCs were analyzed on a FACSscan using Lysis II software (Becton Dickinson, Switzerland). Cytokine assays. The culture supernatants of M-DCs were collected 48 h after treatments. The production of IL-1␤, TNF-␣, IL-12p70 and of IL-10 was measured by ELISA High Sensitivity kits from R&D Systems (U.K.) according to the manufacturer's instructions.
Lymphocyte stimulation test. Autologous T cells were isolated from the non-adherent cell population by magnetic cell depletion (MACS pan T-cell isolation kit, Miltenyi, Germany). The T-cell population contained 60 -70% CD4ϩ cells and 40 -30% CD8ϩ cells, as assessed by flow cytometry (data not shown). T cells (60,000) were co-cultured in round-bottomed 96-well plate (Falcon) with 24-h pretreated M-DCs (10,000) in a final volume of 200 l complete RPMI, 1640 per well, at 37°C in a humidified atmosphere at 5% CO 2 in air. Four replicates of co-culture for each compound concentration were maintained for 5-6 days. T-cell proliferation was assessed by a colorimetric immunoassay based on the measurement of BrdU incorporation during DNA synthesis (cell proliferation ELISA, BrdU, Boehringer, Germany). Results are expressed as proliferation index: OD from untreated M-DCs/OD from treated M-DCs.
RESULTS
Phenotypic and Functional Characterization of the in Vitro Generated M-DCs
The forward/side scatter dot-plot ( Fig. 1) shows the M-DC population that was homogeneous after 7 days of culture. Dual-color analysis presented also in Figure 1 , shows typical profiles of these immature DCs. The cells, which had the typical dendritic morphology, were CD1a bright , whereas HLA-DR antigen was weakly expressed. A weak co-expression of CD80 (B7-1) and CD86 (B7-2) was observed as well as a co-expression of CD40 and CD54 (ICAM-1) antigens. During the differentiation stage, M-DCs lost the expression of the monocytic marker CD14. No contamination of the M-DC culture by T cells, B cells, or NK cells was detected (Fig. 1) . Incubation of these immature M-DCs with 50 ng/ml of TNF-a for 2 days (Fig. 2) elicited a strong expression of HLA-DR and of the co-stimulatory molecules (opened histograms) as compared to non-treated M-DCs (filled histograms). Based on these phenotypic and functional characteristics, all subsequent experiments were performed with M-DCs generated after 7 days of culture with GM-CSF and IL-4.
Phenotypic Maturation of M-DCs Treated with Chemical Allergens vs. the Irritants or the Tolerogen
All substances were used at subtoxic concentration as assessed by a trypan blue exclusion test. Filled histograms (Figs. 3, 4, and 5) show the cell surface phenotype of non-treated M-DCs, from different individuals, at day 7. Opened histograms represent the immunophenotypic analysis of M-DCs treated with the irritants SDS and B.Ac., with the tolerogen DCNB (Enk and Katz, 1992, Rambukkana et al., 1996) and with the vehicle DMSO. The perfect overlay of the different histograms indicated that these compounds exhibited no effect on the surface expression of HLA-DR, CD86, CD40, and CD54 antigens. Similar results were found when a dose-effect was performed with each of these compounds (data not shown). In contrast to these findings, the shift (Fig. 4) of the overlaid opened histograms following M-DCs treatment with the chemical allergens DNCB, 4-AP, Clpz, and with the metal allergen NiSO 4 indicated that M-DCs significantly responded to these haptens by augmenting the expression of HLA-DR, CD86, CD40, and CD54. As exemplified with NiSO 4 used at 30 g/ml (light overlay) and at 50 g/ml (black overlay), the allergen effects were dose-dependent. These data indicated that these haptens induced M-DC phenotypic maturation. The level of these changes was similar to the changes in M-DC phenotype reported by Aiba et al. (1997) . To show the consistency of these phenotypic modifications, we displayed some quantitative measurements of change for HLA-DR, CD86, and CD54 in Figure 5 .
FIG. 5.
Quantitative evaluation of the mean of fluorescence intensity (MFI) changes for HLA-DR, CD86, and CD54 after 2 days incubation with SDS, DCNB, DNCB, 4-AP, Clpz and NiSO 4 (each at 15 g/ml). Results are expressed as MFI Ϯ SEM of 5 independent experiments, using samples derived from different donors.
LPS and Staphylococcal Enterotoxin B Strongly Increased HLA-DR and Co-stimulatory Molecules Expression on M-DCs
To evaluate the efficacy of the haptens on M-DC activation, a comparison was done with LPS. Incubation of M-DCs with 1 ng/ml LPS strongly up-regulated the surface expression of HLA-DR, the co-stimulatory molecule CD86, and the adhesion molecule CD54 (Fig. 6A) . The effect of LPS was dose-dependent and optimal at 100 ng/ml (data not shown). In another set of experiments, the potential of SEB to activate M-DCs was analyzed. Flow cytometric data revealed that, compared with non-treated M-DCs (Fig. 6B) , expression of HLA-DR, CD86, and CD54 was strongly increased at 5 pg/ml SEB. A maximal increment by SEB was observed at 10 pg/ml. In contrast to haptens, in these experiments LPS and SEB did not show an effect on CD40 expression.
Cytokine Release after Exposure of M-DCs to Haptens SEB and LPS
The release of TNF-␣, IL-12p70, and IL-10 was analyzed after 2 days incubation with the irritants (SDS and B.Ac.), the tolerogen (DCNB), the allergens (DNCB, 4-AP, Clpz and NiSO 4 ), or the toxins (LPS and SEB). The basal production of TNF-␣ was enhanced in a dose-dependent manner by the allergens (Fig. 7) , but not by the irritants or the tolerogen. Interestingly, NiSO 4 elicited a stronger TNF-␣ release than the other compounds. SEB appeared as the most potent inducer of TNF-␣ production in this study. Treatment of M-DC with LPS and SEB induced IL-12p70 production by M-DC. However, LPS was found to be the most potent enhancer of IL-12p70 release by M-DCs (Fig. 8) . Analysis of IL-10 in the culture medium showed that M-DCs responded to LPS stimulation, only (Fig.9 ). We were also interested in IL-1␤ production by M-DCs. The kinetic study performed with LPS, SEB, and NiSO 4 as control allergen showed that only LPS was found to induce IL-1␤ release within 24-h stimulation, in contrast to SEB and NiSO 4 which showed no effect (Fig. 10) .
M-DCs Treated with the Chemical Allergens, with SEB and LPS, But Not with the Irritants or the TolerogenStimulated Autologous T cell Proliferation
To associate a biological event with our findings, the stimulatory function of M-DC to autologous T cells was investigated. As indicated in Materials and Methods, the T cell responder populations were free of contaminating DCs (60 -70% CD4Ϯ cells and 40 -30% CD8Ϯ cells). However, these T cells were cultured alone as internal control. They did not proliferate, indicating there was no DC in this preparation (data not shown). Figure 11 represents typical data on T cell proliferation when M-DCs were pre-pulsed for one day with the different compounds. Compared to the level of lymphocyte proliferation in the presence of non-treated M-DCs (proliferation index 1), no T-cell proliferation was observed with irritants-, tolerogen-or vehicle-treated M-DCs. However, when M-DCs were pre-treated with the chemicals or the metal allergens, they significantly induced autologous T-cell proliferation at each tested concentration (proliferation index from 1.2 to 2.2). A strong T-cell proliferation was detected with LPS or SEB pre-pulsed M-DCs (proliferation index above 2). 
DISCUSSION
The present study was designed to understand the in vitro cascade of immunobiological events following exposure of human DCs to various stimuli, including chemicals and bacterial components such as LPS and SEB. DCs were generated in vitro by culturing human monocytes in the presence of GM-CSF and IL-4 (Chapuis et al., 1997) . To ascertain the quality of every new pool of immature M-DCs, after 7 days of differentiating culture they were phenotypically characterized and tested for their ability to respond to TNF-␣, an inflammatory cytokine known to elicit DC maturation (Chen et al., 1998) . As reported by others (Chapuis et al., 1997; Meierhoff and Krause, 1998) , immature M-DCs were CD1a-positive, MHC class II antigens were weakly expressed, and M-DCs were also positive for co-stimulatory molecules but lacked CD14 antigen. Immature M-DCs with a high-level expression of HLA-DR molecules were discarded, since they were found to be poor or even non-responders to inflammatory stimuli (data not shown). In this report, we show that incubation of M-DCs for 2 days with TNF-␣ resulted in a strong enhancement of the surface expression of HLA-DR and co-stimulatory molecules. These changes were referred to as maturation of DCs (Cella et al., 1997; Steinman, 1991) . This event includes the silencing of antigen up-take by endocytosis, the up-regulation of surface molecules related to T-cell activation, and the active production of a number of cytokines. Considering these M-DCs to be functional DCs, their response to chemical allergens of different sensitizing potential, to irritants, and to a tolerogen was assessed. Each of these assays was performed with some internal controls (data not shown). TNF-␣ (but also LPS or NiSO 4, later on) was used as a strong positive stimulus, and we used the irritant SDS (minimal M-DC response) as negative control.
The observations reported here showed that only representative haptens such as DNCB, 4-AP, Clpz, and NiSO 4 increased the surface expression of HLA-DR, CD86, CD40, and CD54. No significant difference in the cell-surface molecule expression was noticed regarding the sensitizing potential of these allergens. Interestingly, M-DCs always responded to NiSO 4 , a moderate allergen, by a higher increase in expression of co-stimulatory molecules and of HLA-DR antigen than to the other tested haptens. Similar observations were reported by Aiba et al. (1997) . These differences could result from the engagement of different signaling pathways upon binding of the hapten to M-DCs . Thus, the sensitization potential of a chemical may be dependent on its ability to associate with and stimulate DCs, as suggested by the study of Botham et al. (1987) . Slight individual variations were observed regarding the phenotype of immature M-DCs and their phenotypic maturation. Therefore, a well-characterized positive control was included in each experiment in order to rate the strength of the response between inactivated M-DCs and strongly activated cells. LPS was used as positive control, since DCs are highly responsive to such inflammatory stimuli . Under the influence of LPS, M-DCs dramatically up-regulated the expression of HLA-DR and costimulatory molecules, almost as much as with TNF-␣. In a similar fashion, at the concentrations used, SEB demonstrated the same potency as LPS in term of an increased expression of the surface molecules, which is associated with the activation/ maturation of DCs (Steinman, 1991) . Thus, our findings suggested that M-DCs differentiated into "mature" DCs following incubation with chemical haptens, a metal allergen, and the bacterial components tested in this study.
Cytokines such as TNF-␣ and IL-12 play important roles in inflammatory processes and in the induction of specific immune responses. Messenger RNAs for these cytokines have been detected in M-DCs (Matsuyama et al. 1993) . To further investigate the potency of the haptens SEB and LPS to drive M-DC maturation, cytokine production was examined. Kinetic studies performed with the different haptens indicated that, during the 2 days of incubation, there was an accumulation of the cytokines in the supernatants when compared to a 1-day incubation (data not shown). Thus, measurements were performed at day 2 of stimulation. Interestingly, the effect of the haptens on the M-DC phenotype was accompanied by production of TNF-␣. NiSO 4 , which elicited a strong cell-surface expression of HLA-DR and co-stimulatory molecules in comparison to the other haptens, and also demonstrated greater potential to induce TNF-␣ release. In agreement with these observations, the irritants and the tolerogen showed no effect, while LPS and SEB were powerful stimulators of TNF-␣ synthesis.
These findings highlighted the capacity of bacterial compo- nents and haptens to trigger DCs phenotypic maturation, probably via the production of TNF-␣. The basal production of IL-12p70 and IL-10 was unchanged following incubation with either allergens or irritants. The superantigen SEB was found to induce the production of IL-12p70 but not IL-10, whereas LPS induced substantial levels of both cytokines. These results are supported by the observations that MHC class-II positive cells, when stimulated by LPS, produce large amounts of IL-12p70, while IL-12p70 production via CD40 ligation requires IFN-␥ as an obligatory, complementary signal (De Saint-Vis et al. 1998; Ma et al., 1996) . Thus, the cytokine profile expressed by human DCs seems to depend on the mode of activation (Matsuyama et al., 1993) , suggesting that other factors may be required in vitro for the induction of these cytokines by haptens. The observation of Aiba et al. (1997) that IL-1␤ was released by hapten-treated M-DCs (5-days old), could not be corroborated in this study. Further studies will have to address IL-1␤ gene expression following exposure of M-DC to chemical haptens. However, the results on the mRNA level have to be compared with the amount of intracellularly stored protein and the potency of M-DC to release IL-1␤ under in vitro conditions.
Collectively, these results implied that chemicals or metal allergens, as well as bacterial components, might subsequently affect the antigen-presenting function of M-DCs. Evaluation of the immunocompetence of treated M-DCs showed that, indeed, the haptens, but not the irritants or the tolerogen, conferred T cell-stimulating activity of M-DCs. The same observation was made for LPS and SEB. These data demonstrated that M-DCs can respond "selectively" to chemicals and to inflammatory stimuli by changing their expression of HLA-DR and by costimulatory molecules and their production of TNF-␣. Hence, after further evaluation using standard chemicals, in vitrogenerated human DCs might become a valuable tool for mechanistic studies and for discriminating potential allergens from non-allergenic compounds.
